Nelson Obus And Wynnefield Capital Further Boost Their Stake In Nature’s Sunshine Prod. (NATR)

Nelso Obus is still bullish on Nature’s Sunshine Prod. (NASDAQ:NATR) and has further increased his fund’s investment in the stock. According to a recent Form 4 filing with the Securities and Exchange Commission, Wynnefield Capital has acquired 19,900 shares in 9 transactions at prices varying between $15.9 and $16 per unit. The fund recently reported the addition of 20,851 Nature’s Sunshine Prod. (NASDAQ:NATR) shares to its previous stake in the company. Wynnefield currently holds approximately 1.71 million shares.

Nelson Obus

Jim Simons, the manager of Renaissance Technologies, is also bullish on Nature’s Sunshine Prod. (NASDAQ:NATR) and has increased his investment by 32% during the first three months of 2014. The company is also on the radar of Willem Mesdag, the manager of Red Mountain Capital. During the first quarter, Red Mountain has not made any changes to its holding of the stock – 2.43 million shares. Phil Frohlich is also betting on Nature’s Sunshine Prod. (NASDAQ:NATR), with his fund, Prescott Group Capital Management, holding 1.86 million shares.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!